Posted by klein on April 28, 2014, at 10:11:52
In reply to Re: Agomelatine in USA, posted by Louisiana Sportsman on April 27, 2014, at 20:37:25
> The USA also has Fetzima which is Forest's recently approved levomilnacipran extended-release capsules that are indicated for MDD but not fibromyalgia.
>I forgot all about Fetzima, Louisiana. Its approval for MDD is very significant I think. Milnacipran is a good anti-depressant. Fetzima's side effect profile looks a bit better than Savella's, though, at least on paper. Have you tried either one? I stopped Savella because it was making me extremely drowsy, the exact opposite of what I had been hoping for. The hiperhidrosis was ridiculously bad too, but my pdoc came up with a solution that worked very well (Ditropan).
Hmm.. I notice that levomilnacipran was identified by Fabre back in 2000. I have to wonder if this isn't a new marketing technique, like a "reverse evergreening" of sorts. Maybe Forest didn't push Savella's approval for MDD hard enough, opting for an exclusive fibro indication instead because they knew levomilnacipran was in the pipeline.. so now they have two "different" products (one for fibro, the other for MDD) under patent protection til 2020+.
poster:klein
thread:1064857
URL: http://www.dr-bob.org/babble/20140419/msgs/1064886.html